Natural Killer T Cells and Atherosclerosis: Form and Function Meet Pathogenesis

被引:28
|
作者
Braun, Nicole A. [2 ]
Covarrubias, Roman [2 ]
Major, Amy S. [1 ,2 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Dept Mol Pathol, Nashville, TN 37232 USA
关键词
Adaptive immunity; Atherosclerosis; Chronic inflammation; Dyslipidemia; Immune regulation; Innate immunity; Natural killer T cells; LOW-DENSITY-LIPOPROTEIN; E-DEFICIENT MICE; CORONARY-ARTERY-DISEASE; INVARIANT NKT CELLS; RECEPTOR-NULL MICE; OXIDIZED LDL; AUTOIMMUNE ENCEPHALOMYELITIS; BETA(2)-GLYCOPROTEIN I; PROTECTIVE IMMUNITY; MEDIATED ACTIVATION;
D O I
10.1159/000296915
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Atherosclerosis is a chronic inflammatory disease characterized by dyslipidemia and accumulation of lipids in the arterial intima, with activation of both innate and adaptive immunity. Reciprocally, dyslipidemia associated with atherosclerosis can perturb normal immune function. Natural killer T (NKT) cells are a specialized group of immune cells that share characteristics with both conventional T cells and natural killer cells. However, unlike these cells, NKT cells recognize glycolipid antigens and produce both pro- and anti-inflammatory cytokines upon activation. Because of these unique characteristics, NKT cells have recently been ascribed a role in the regulation of immunity and inflammation, including cardiovascular disease. In addition, NKT cells represent a bridge between dyslipidemia and immune regulation. This review summarizes the current knowledge of NKT cells and discusses the interplay between dyslipidemia and the normal functions of NKT cells and how this might modulate inflammation and atherosclerosis. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:316 / 324
页数:9
相关论文
共 50 条
  • [1] Natural killer T cells in atherosclerosis
    Godfrey S. Getz
    Catherine A. Reardon
    Nature Reviews Cardiology, 2017, 14 : 304 - 314
  • [2] Natural killer T cells in atherosclerosis
    Getz, Godfrey S.
    Reardon, Catherine A.
    NATURE REVIEWS CARDIOLOGY, 2017, 14 (05) : 304 - 314
  • [3] Natural killer T cells in atherosclerosis - Response
    Charo, IF
    Aslanian, AM
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (05) : E40 - E40
  • [4] Natural killer T cells in lipoprotein metabolism and atherosclerosis
    Getz, Godfrey S.
    VanderLaan, Paul A.
    Reardon, Catherine A.
    THROMBOSIS AND HAEMOSTASIS, 2011, 106 (05) : 814 - 819
  • [5] Human natural killer cells: Form, function, and development
    Mace, Emily M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : 371 - 385
  • [6] Natural killer cells and natural killer T cells
    Seaman, WE
    ARTHRITIS AND RHEUMATISM, 2000, 43 (06): : 1204 - 1217
  • [7] The regulatory function of the invariant natural killer T cells
    Engelmann, Peter
    Kis, Janos
    Richman, Geoffrey
    Eck, Shawn
    Jalahey, Heyam
    Orban, Tihamer
    DIABETES, 2006, 55 : A278 - A278
  • [8] Activation of natural killer T cells with α-galactosylceramide accelerates atherosclerosis in mice
    Nakai, Y
    Iwabuchi, K
    Mishima, T
    Ishimori, N
    Watano, K
    Onoe, K
    Van Kaer, L
    Kitabatake, A
    CIRCULATION, 2003, 108 (17) : 163 - 163
  • [9] Participatory role of natural killer and natural killer T cells in atherosclerosis: lessons learned from in vivo mouse studies
    Whitman, SC
    Ramsamy, TA
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2006, 84 (01) : 67 - 75
  • [10] Invariant natural killer T cells: Linking inflammation and neovascularization in human atherosclerosis
    Kyriakakis, Emmanouil
    Cavallari, Marco
    Andert, Jan
    Philippova, Maria
    Koella, Christoph
    Bochkov, Valery
    Erne, Paul
    Wilson, S. Brian
    Mori, Lucia
    Biedermann, Barbara C.
    Resink, Therese J.
    De Libero, Gennaro
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2010, 40 (11) : 3268 - 3279